Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 683 | 488 | 386 | 359 | 366 |
| Gross Profit | 683 | 488 | 386 | 359 | 366 |
| Operating Expenses | 49,334 | 45,900 | 40,288 | 29,214 | 19,452 |
| Operating Income | -48,651 | -45,412 | -39,902 | -28,855 | -19,086 |
| Interest Expense | 0 | 0 | 0 | 0 | 2 |
| Other Income | 3,220 | 3,971 | 1,198 | 564 | -219 |
| Pre-tax Income | -45,431 | -41,441 | -38,704 | -28,291 | -19,307 |
| Net Income Continuous | -45,431 | -41,441 | -38,704 | -28,291 | -19,307 |
| Net Income | $-45,431 | $-41,441 | $-38,704 | $-28,291 | $-19,307 |
| EPS Basic Total Ops | -0.95 | -0.93 | -0.89 | -0.73 | -1.08 |
| EPS Basic Continuous Ops | -0.95 | -0.93 | -0.89 | -0.72 | -0.92 |
| EPS Diluted Total Ops | -0.95 | -0.93 | -0.89 | -0.73 | -1.08 |
| EPS Diluted Continuous Ops | -0.95 | -0.93 | -0.89 | -0.72 | -0.92 |
| EPS Diluted Before Non-Recurring Items | -0.95 | -0.93 | -0.89 | -0.73 | -1.08 |
| EBITDA(a) | $-48,845 | $-45,935 | $-39,034 | $-26,797 | $-18,620 |